Int Clin Psychopharmacol, Vol. 22, No. 6. (November 2007), pp. 330-337.
Drug Saf, Vol. 30, No. 7. (2007), pp. 555-567.
Mov Disord, Vol. 22, No. 4. (15 March 2007), pp. 570-573.
Biomedecine & Pharmacotherapy, Vol. 60, No. 7. (August 2006), pp. 318-322.
CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 6, No. 1. (February 2007), pp. 17-29.
N Engl J Med (28 March 2007)
by Gary S S
Sachs, Andrew A A
Nierenberg, Joseph R R
Calabrese, Lauren B B
Marangell, Stephen R R
Wisniewski, Laszlo
Gyulai, Edward S S
Friedman, Charles L L
Bowden, Mark D D
Fossey, Michael J J
Ostacher, Terence A A
Ketter, Jayendra
Patel, Peter
Hauser, Daniel
Rapport, James M M
Martinez, Michael H H
Allen, David J J
Miklowitz, Michael W W
Otto, Ellen B B
Dennehy, Michael E E
Thase
Drug Safety, Vol. 30, No. 2. (2007), pp. 171-184.
CNS Drugs, Vol. 20, No. 3. (2006), pp. 187-198.
Drug Saf, Vol. 29, No. 2. (2006), pp. 95-118.
Am J Psychiatry, Vol. 164, No. 2. (1 February 2007), pp. 342-345.
British Journal of Clinical Pharmacology, Vol. 61, No. 2. (February 2006), pp. 191-199.
Neurology, Vol. 67, No. 11. (12 December 2006), pp. 1916-1925.
CNS Spectr, Vol. 10, No. 3. (March 2005), pp. 224-232.
Am J Psychiatry, Vol. 163, No. 7. (July 2006), pp. 1199-1201.
Clin Neuropharmacol, Vol. 29, No. 5. (t 2006), pp. 265-268.
J Psychopharmacol, Vol. 19, No. 3. (May 2005), pp. 287-291.